EME Medical
EME Medical › Drug encyclopedia

💊 Insulin aspart (Fiasp)

💊 Rapid-acting insulin analog (Insulin Analog)

Insulin aspart (Fiasp) is a rapid-acting human insulin analog used to improve blood sugar control in adults and children with diabetes mellitus. It is given by subcutaneous injection or insulin pump, and in specific situations by intravenous infusion under medical supervision. Your doctor or pharmacist sets the dose that is right for you.

🏷️ Brands: Fiasp💉 Subcutaneous📋 Prescription only
In Arabic: إنسولين أسبارت

🏷️ Brand names & manufacturers

Novolog Mix 70/30 — Novo Nordisk Pharmaceutical Industries, LPNovolog Mix 70/30🏭 Novo Nordisk Pharmaceutical Industries, LPDailyMed
Insulin Diluting Medium For Novolog — Novo NordiskInsulin Diluting Medium For Novolog🏭 Novo NordiskDailyMed
Fiasp — Novo NordiskFiasp🏭 Novo NordiskDailyMed
Insulin Aspart Protamine And Insulin Aspart Mix 70/30 — Novo Nordisk Pharma, Inc.Insulin Aspart Protamine And Insulin Aspart Mix 70/30🏭 Novo Nordisk Pharma, Inc.DailyMed
Insulin Aspart — Novo Nordisk Pharma, Inc.Insulin Aspart🏭 Novo Nordisk Pharma, Inc.DailyMed
Packages shown are US-market (DailyMed). Brands available in Palestine are in the price section below.

✅ What it is used for

🧪 Active ingredient

Insulin aspart: an insulin analog that regulates glucose metabolism. It binds to insulin receptors, lowering blood glucose by facilitating glucose uptake into skeletal muscle and fat tissue and by inhibiting glucose output from the liver; it also inhibits lipolysis and proteolysis and enhances protein synthesis.

🌿 Benefits

📝 How to use

💊 Dosage forms

⚠️ Common side effects

  • Hypoglycemia
  • Injection/infusion site reactions
  • Lipodystrophy
  • Weight gain
  • Nasopharyngitis and upper respiratory tract infection
  • Nausea, diarrhea and back pain (in some trials)
  • Urinary tract infection (in type 2 diabetes trial)
  • Headache, fever, vomiting and influenza (in children)

🚨 Serious — seek medical help

  • Severe, potentially life-threatening hypoglycemia
  • Potentially life-threatening hypokalemia
  • Severe hypersensitivity reactions, including generalized allergy and anaphylaxis
  • Fluid retention and heart failure when used with thiazolidinediones (TZDs)
  • Hyperglycemia and ketoacidosis due to insulin pump malfunction

⛔ Do not use if

❗ Warnings & precautions

🔄 Drug interactions

🤰 Pregnancy

There are no available data with Fiasp in pregnant women to assess the risk of major birth defects or miscarriage. Published randomized trials of insulin aspart used during the second trimester did not report an association with major birth defects or adverse maternal or fetal outcomes. Poorly controlled diabetes in pregnancy poses risks to mother and fetus, so consult your doctor.

🍼 Breastfeeding

The label text provided does not contain lactation information; consult your doctor before use while breastfeeding.

🧒 Children

Safety and effectiveness of Fiasp have been established to improve glycemic control in pediatric patients with diabetes mellitus (study in patients with type 1 diabetes aged 2 to 17 years). Pediatric patients had a higher rate of blood glucose confirmed hypoglycemic episodes than with NovoLog, especially at night, so blood glucose should be monitored closely.

👴 Older adults

No overall differences in safety or effectiveness were observed between elderly and younger adult patients, but caution is advised; initial dosing, dose increments and maintenance dosage should be conservative to avoid hypoglycemia.

🌡️ Storage

Unused vials: store in a refrigerator at 2°C to 8°C (36°F to 46°F), not in or near the freezing compartment. Never freeze and do not use if frozen. Protect from excessive heat and light and keep in the original carton. Do not draw into a syringe for later use. Keep the pen cap on to protect from light; remove the needle after each injection and use a new needle each time. In-use or unopened vials and FlexTouch pens may be kept for 28 days at room temperature (up to 30°C [86°F]).

⏰ Missed dose

If you miss a mealtime dose on a basal-bolus regimen, check your blood glucose to decide whether an insulin dose is needed, then resume your usual schedule at the next meal. Ask your doctor if unsure.

🆘 Overdose

Excess insulin may cause hypoglycemia and hypokalemia. Mild episodes are usually treated with oral glucose; dose, meal pattern or exercise adjustments may be needed. Severe episodes with coma, seizure or neurologic impairment may be treated with intramuscular/subcutaneous glucagon or concentrated intravenous glucose. Sustained carbohydrate intake and observation may be necessary as hypoglycemia may recur. Hypokalemia must be corrected. Seek medical help immediately.

💰 Price & brands in your area

Local prices are currently available for Palestine; more countries are coming. Ask your pharmacist for local price and alternatives.

📍 Find the nearest pharmacy

Your location is used only in your browser to show nearby pharmacies — we don't store it.

Open in Google Maps

👨‍⚕️ For healthcare professionals

Mechanism of action

Insulin aspart binds insulin receptors, increasing glucose uptake in skeletal muscle and adipose tissue and inhibiting hepatic glucose output; it inhibits lipolysis and proteolysis and enhances protein synthesis. It is a rapid-acting analog homologous to human insulin except for proline-to-aspartic acid substitution at B28, produced by recombinant DNA technology in Saccharomyces cerevisiae. Onset is about 16-20 minutes, peak effect about 91-133 minutes, and effect returns to baseline in about 5-7 hours depending on dose.

Labeled dosing

Individualize and adjust dosage based on route of administration, metabolic needs, blood glucose monitoring results and glycemic goal. Subcutaneous injection at the start of a meal or within 20 minutes after starting a meal, generally with an intermediate- or long-acting insulin. May be given by continuous subcutaneous infusion via pump, or intravenously under medical supervision after dilution to 0.5-1 unit/mL in polypropylene infusion bags. Dose adjustments may be needed when switching insulins or with changes in physical activity, concomitant medications, meal patterns, renal/hepatic function or acute illness. The FlexTouch pen dials in 1-unit increments.

🎓 Key points for students

🩺 Run a clinic or medical center?

EME runs your whole clinic: appointments with WhatsApp reminders, patient files, finance & inventory, a patient portal and a members-price medical store — with your data isolated and protected.

Try EME free   How we protect your data

❓ FAQ

What is Fiasp (insulin aspart) used for?

It is used to improve blood sugar control in adults and children with diabetes mellitus.

When should Fiasp be injected relative to a meal?

At the start of a meal or within 20 minutes after starting a meal. Your doctor or pharmacist determines your dose.

Can it be mixed with another insulin?

No, Fiasp must not be mixed with any other insulin.

What are the main side effects?

The main ones are hypoglycemia, injection site reactions, lipodystrophy, weight gain, and allergic reactions.

How should I store it?

Store unused product in a refrigerator (2°C to 8°C) without freezing, away from heat and light. Once in use it may be kept up to 28 days at room temperature (up to 30°C [86°F]) or in the refrigerator.

Can I share my pen with someone else?

No. Never share pens, cartridges or needles, even if the needle is changed, because of the risk of transmitting infections.

⚕️ For education only — not a substitute for advice from your doctor or pharmacist. Do not start or stop any medicine without advice. Source: official FDA drug label via openFDA (2023-06), simplified. Updated: 2026-11-16.